All Stories

  1. SERS-based differential diagnosis between multiple solid malignancies: breast, colorectal, lung, ovarian and oral cancer

    Article • International Journal of Nanomedicine, August 2019, Dove Medical Press

    Lajos Raduly, Dr Mihai-Stefan Muresan, Professor Berindan Neagoe I Ioana, Marioara Simon

  2. Food toxicology: quantitative analysis of the research field literature

    Article • International Journal of Food Sciences and Nutrition, May 2019, Taylor & Francis

    Assoc. Prof. Dr. Nikolay T. Tzvetkov, Ferdinando Nicoletti, Professor Berindan Neagoe I Ioana, Timea Polgar

  3. Mesenchymal stem cells in myeloproliferative disorders – focus on primary myelofibrosis

    Article • Leukemia & Lymphoma, October 2018, Taylor & Francis

    Professor Berindan Neagoe I Ioana, Graca Almeida-Porada

  4. Decoding the Emerging Patterns Exhibited in Non-coding RNAs Characteristic of Lung Cancer with Regard to Their Clinical Significance

    Article • Current Genomics, March 2018, Bentham Science Publishers

    Professor Berindan Neagoe I Ioana, Mihail Buse

  5. MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation

    Article • Annals of Hematology, April 2015, Springer Science + Business Media

    Professor Berindan Neagoe I Ioana

  6. Dual Targeted Therapy with p53 siRNA and Epigallocatechingallate in a Triple Negative Breast Cancer Cell Model

    Article • PLoS ONE, April 2015, PLOS

    Professor Berindan Neagoe I Ioana, Mrs Roxana M Cojocneanu Petric

  7. Pharmacokinetics Evaluation of Carbon Nanotubes Using FTIR Analysis and Histological Analysis

    Article • Journal of Nanoscience and Nanotechnology, April 2015, American Scientific Publishers

    Mrs Roxana M Cojocneanu Petric, Professor Berindan Neagoe I Ioana, Dr Cristian Tudor Matea

  8. The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis

    Article • Gut, March 2015, BMJ

    Professor Berindan Neagoe I Ioana

  9. Epigallocatechin-3-gallate suppresses cell proliferation and promotes apoptosis and autophagy in oral cancer SSC-4 cells

    Article • OncoTargets and Therapy, February 2015, Taylor & Francis

    Professor Berindan Neagoe I Ioana

  10. Junk DNA and the long non-coding RNA twist in cancer genetics

    Article • Oncogene, January 2015, Springer Science + Business Media

    Professor Berindan Neagoe I Ioana

  11. Novel technologies for oral squamous carcinoma biomarkers in diagnostics and prognostics

    Article • Acta Odontologica Scandinavica, January 2015, Taylor & Francis

    Mrs Roxana M Cojocneanu Petric, Professor Berindan Neagoe I Ioana

  12. Clinical and pathological implications of miRNA in bladder cancer

    Article • International Journal of Nanomedicine, January 2015, Taylor & Francis

    Dr TRUTA Anamaria, Mrs Roxana M Cojocneanu Petric, Professor Berindan Neagoe I Ioana, Dr. Alexandru G. Floares

  13. Exposure to zearalenone mycotoxin alters in vitro porcine intestinal epithelial cells by differential gene expression

    Article • Toxicology Letters, January 2015, Elsevier

    Professor Berindan Neagoe I Ioana

  14. Molecular Pathways: microRNAs, Cancer Cells, and Microenvironment

    Article • Clinical Cancer Research, December 2014, American Association for Cancer Research (AACR)

    Professor Berindan Neagoe I Ioana

  15. The Synthesis and Antiproliferative Activities of New Arylidene-Hydrazinyl-Thiazole Derivatives

    Article • International Journal of Molecular Sciences, December 2014, MDPI AG

    Professor Berindan Neagoe I Ioana

  16. Professor Stelian Neagoe 1949-2014

    Article • Romanian Journal of Diabetes Nutrition and Metabolic Diseases, December 2014, De Gruyter

    Professor Berindan Neagoe I Ioana

  17. NCRNA Combined Therapy as Future Treatment Option for Cancer

    Article • Current Pharmaceutical Design, October 2014, Bentham Science Publishers

    Professor Berindan Neagoe I Ioana

  18. PDGF beta targeting in cervical cancer cells suggest a fine-tuning of compensatory signalling pathways to sustain tumourigenic stimulation

    Article • Journal of Cellular and Molecular Medicine, October 2014, Wiley

    Professor Berindan Neagoe I Ioana

  19. Exosomes as divine messengers: are they the Hermes of modern molecular oncology?

    Article • Cell Death and Differentiation, September 2014, Springer Science + Business Media

    Professor Berindan Neagoe I Ioana

  20. Non-Coding RNAs as Theranostics in Human Cancers

    Article • Journal of Cellular Biochemistry, September 2014, Wiley

    Professor Berindan Neagoe I Ioana

  21. MiRNA Expression Assays

    Article • September 2014, Springer Science + Business Media

    Professor Berindan Neagoe I Ioana

  22. BCR–ABL1T315I mutation, a negative prognostic factor for the terminal phase of chronic myelogenous leukemia treated with first- and second-line tyrosine kinase inhibitors, might be an indicator of allogeneic stem cell transplant as the treatment of choice

    Article • Leukemia & Lymphoma, August 2014, Taylor & Francis

    Professor Berindan Neagoe I Ioana

  23. Magnetic resonance imaging-based diagnosis of progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma after therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab

    Article • Cancer, August 2014, Wiley

    Professor Berindan Neagoe I Ioana

  24. MicroRNAome genome: A treasure for cancer diagnosis and therapy

    Article • CA A Cancer Journal for Clinicians, August 2014, American Cancer Society

    Professor Berindan Neagoe I Ioana

  25. Differential Peripheral Blood Gene Expression Profile Based on Her2 Expression on Primary Tumors of Breast Cancer Patients

    Article • PLoS ONE, July 2014, PLOS

    Professor Berindan Neagoe I Ioana, Dr Ovidiu D Balacescu

  26. Dose intensity and autologous stem cell transplantation as salvage therapy for pediatric primary CNS malignancies

    Article • International Journal of Nanomedicine, July 2014, Taylor & Francis

    Professor Berindan Neagoe I Ioana

  27. Nanopharmacology in translational hematology and oncology

    Article • International Journal of Nanomedicine, July 2014, Taylor & Francis

    Professor Berindan Neagoe I Ioana

  28. Epigenetically regulated microRNAs and their prospect in cancer diagnosis

    Article • Expert Review of Molecular Diagnostics, June 2014, Taylor & Francis

    Professor Berindan Neagoe I Ioana

  29. Interplay between cancer cells, macrophages and natural killer cells may actually decide the outcome of therapy with sorafenib

    Article • Hepatology, May 2014, Wolters Kluwer Health

    Professor Berindan Neagoe I Ioana

  30. N-BLR, a primate-specific non-coding transcript, modulates the epithelial-to-mesenchymal transition and leads to colorectal cancer invasion and migration

    Article • May 2014, Cold Spring Harbor Laboratory Press

    Professor Berindan Neagoe I Ioana

  31. Gene expression profiling reveals activation of the FA/BRCA pathway in advanced squamous cervical cancer with intrinsic resistance and therapy failure

    Article • BMC Cancer, April 2014, Springer Science + Business Media

    Professor Berindan Neagoe I Ioana, Dr Ovidiu D Balacescu

  32. Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery

    Article • Tumor Biology, February 2014, Springer Science + Business Media

    Professor Berindan Neagoe I Ioana

  33. MRI-based identification of undifferentiated cells: looking at the two faces of Janus

    Article • International Journal of Nanomedicine, February 2014, Taylor & Francis

    Professor Berindan Neagoe I Ioana

  34. Identification of Circulating MicroRNA Signatures for Breast Cancer Detection

    Article • Breast Diseases A Year Book Quarterly, January 2014, Elsevier

    Professor Berindan Neagoe I Ioana

  35. The role of staphylococcal enterotoxin A in achieving oral tolerance to myelin basic protein in adult mice

    Article • Immunological Investigations, December 2013, Taylor & Francis

    Professor Berindan Neagoe I Ioana

  36. The relationship between the structure and biological actions of green tea catechins

    Article • Food Chemistry, December 2013, Elsevier

    Professor Berindan Neagoe I Ioana

  37. Another review on triple negative breast cancer. Are we on the right way towards the exit from the labyrinth?

    Article • The Breast, December 2013, Elsevier

    Professor Berindan Neagoe I Ioana

  38. Abstract C6: Molecular and cellular signaling of PDGFB in cervical cancer cells.

    Article • Molecular Cancer Therapeutics, November 2013, American Association for Cancer Research (AACR)

    Professor Berindan Neagoe I Ioana

  39. Sorafenib for the treatment of solid malignancies: what about the cancer microenvironment?

    Article • International Journal of Nanomedicine, October 2013, Taylor & Francis

    Professor Berindan Neagoe I Ioana

  40. Electrochemical immunosensors in breast and ovarian cancer

    Article • Clinica Chimica Acta, October 2013, Elsevier

    Professor Berindan Neagoe I Ioana

  41. One step synthesis of SERS active colloidal gold nanoparticles by reduction with polyethylene glycol

    Article • Colloids and Surfaces A Physicochemical and Engineering Aspects, September 2013, Elsevier

    Professor Berindan Neagoe I Ioana

  42. MicroRNAs and Cancer Therapy – From Bystanders to Major Players

    Article • Current Medicinal Chemistry, August 2013, Bentham Science Publishers

    Professor Berindan Neagoe I Ioana

  43. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer

    Article • Genome Research, June 2013, Cold Spring Harbor Laboratory Press

    Professor Berindan Neagoe I Ioana

  44. p53siRNA therapy reduces cell proliferation, migration and induces apoptosis in triple negative breast cancer cells

    Article • Molecular and Cellular Biochemistry, June 2013, Springer Science + Business Media

    Professor Berindan Neagoe I Ioana

  45. Oxaliplatin induces different cellular and molecular chemoresistance patterns in colorectal cancer cell lines of identical origins

    Article • BMC Genomics, January 2013, Springer Science + Business Media

    Professor Berindan Neagoe I Ioana, Dr Ovidiu D Balacescu

  46. Epigallocatechin-3-Gallate (EGCG) Inhibits Cell Proliferation and Migratory Behaviour of Triple Negative Breast Cancer Cells

    Article • Journal of Nanoscience and Nanotechnology, January 2013, American Scientific Publishers

    Professor Berindan Neagoe I Ioana

  47. TNF-α Gene Knockout in Triple Negative Breast Cancer Cell Line Induces Apoptosis

    Article • International Journal of Molecular Sciences, December 2012, MDPI AG

    Professor Berindan Neagoe I Ioana

  48. Combining the chemotherapeutic effects of epigallocatechin 3-gallate with siRNA-mediated p53 knock-down results in synergic pro-apoptotic effects

    Article • International Journal of Nanomedicine, December 2012, Taylor & Francis

    Professor Berindan Neagoe I Ioana

  49. Efficient siRNA Delivery System Using Carboxilated Single-Wall Carbon Nanotubes in Cancer Treatment

    Article • Journal of Biomedical Nanotechnology, August 2012, American Scientific Publishers

    Dr Cristian Tudor Matea, Professor Berindan Neagoe I Ioana

  50. 247 Alterations of Cellular and Molecular Patterns in Oxaliplatin Resistant Colorectal Adenocarcinoma Cell Lines

    Article • European Journal of Cancer, July 2012, Elsevier

    Professor Berindan Neagoe I Ioana

  51. Early Apoptosis Signals Induced by a Low Dose of Epigallocatechin 3-Gallate Interfere with Apoptotic and Cell Death Pathways

    Article • Journal of Nanoscience and Nanotechnology, March 2012, American Scientific Publishers

    Professor Berindan Neagoe I Ioana, Dr Ovidiu D Balacescu

  52. Early transcriptional pattern of angiogenesis induced by EGCG treatment in cervical tumour cells

    Article • Journal of Cellular and Molecular Medicine, February 2012, Wiley

    Professor Berindan Neagoe I Ioana, Dr Ovidiu D Balacescu

  53. The Relationships Between Biological Activities and Structure of Flavan-3-Ols

    Article • International Journal of Molecular Sciences, December 2011, MDPI AG

    Professor Berindan Neagoe I Ioana, Dr Ovidiu D Balacescu

  54. Molecular Angiogenesis Profile as a Tool to Discriminate Chronic Pancreatitis (CP) From Pancreatic Cancer (PC)

    Article • Pancreas, April 2011, Wolters Kluwer Health

    Professor Berindan Neagoe I Ioana, Dr Ovidiu D Balacescu

  55. Non-coding RNAs as theranostics in human cancers

    Article • Journal of Cellular Biochemistry, January 2011, Wiley

    Professor Berindan Neagoe I Ioana

  56. Hybridization Dynamics Compensation in Microarray Experiments

    Article • January 2011, Springer Science + Business Media

    Professor Berindan Neagoe I Ioana

  57. INDIVIDUAL AND COMBINED CYTOTOXIC EFFECTS OF THE MAJOR FOUR AFLATOXINS IN DIFFERENT IN VITRO STABILIZED SYSTEMS

    Article • Journal of Food Biochemistry, March 2010, Wiley

    Professor Berindan Neagoe I Ioana

  58. PROTECTIVE ACTION OF DIFFERENT NATURAL FLAVAN-3-OLS AGAINST AFLATOXIN B1-RELATED CYTOTOXICITY

    Article • Journal of Food Biochemistry, March 2010, Wiley

    Professor Berindan Neagoe I Ioana, Dr Ovidiu D Balacescu

  59. Th1 and Th2 Profiles in Patients With Pancreatic Cancer Compared With Chronic Pancreatitis

    Article • Pancreas, July 2009, Wolters Kluwer Health

    Professor Berindan Neagoe I Ioana

  60. Angiogenesis Serum Protein Quantification for Prostate Pathology

    Article • Current Urology, March 2009, Wolters Kluwer Health

    Professor Berindan Neagoe I Ioana, Dr Ovidiu D Balacescu

  61. Apoptosis in cancer: Key molecular signaling pathways and therapy targets

    Article • Acta Oncologica, January 2009, Taylor & Francis

    Professor Berindan Neagoe I Ioana, Dr Ovidiu D Balacescu

  62. LASER - BASED PROTEIN ARRAY TH1/TH2 PROFILING IS USEFUL FOR PANCREATIC CANCER DIAGNOSIS

    Article • Pancreas, November 2008, Wolters Kluwer Health

    Professor Berindan Neagoe I Ioana

  63. Angiogenesis Serum Protein Quantification for Prostate Pathology

    Article • Current Urology, January 2008, Karger Publishers

    Professor Berindan Neagoe I Ioana, Dr Ovidiu D Balacescu

  64. CLC chloride channels and transporters

    Article • Current Opinion in Neurobiology, June 2005, Elsevier

    Professor Berindan Neagoe I Ioana

  65. Differental loss E-cadherin in breast carcinomas

    Article • European Journal of Cancer, September 1999, Elsevier

    Professor Berindan Neagoe I Ioana

  66. Immune implications of cytostatics loaded in drug carriers of second generation. nanoparticles

    Article • European Journal of Cancer, September 1999, Elsevier

    Professor Berindan Neagoe I Ioana

  67. Fibronectin in cell adhesion. It's expression in breast tumors

    Article • European Journal of Cancer, September 1999, Elsevier

    Professor Berindan Neagoe I Ioana

  68. Correlation between proliferating cell nuclear antigen (PCNA) and p53 protein expression in breast carcinomas. Can they have a prognostic value?

    Article • European Journal of Cancer, September 1999, Elsevier

    Professor Berindan Neagoe I Ioana

  69. Immunohistochemical studies on oncogene products (C-erbB-2) and p53 protein in human breast cancer: is it significant for tumor evolution?

    Article • European Journal of Cancer, September 1999, Elsevier

    Professor Berindan Neagoe I Ioana

  70. 170-P-Glycoproteins in multidrug resistance. Immunohistochemical assays with MoAb

    Article • European Journal of Cancer, September 1997, Elsevier

    Professor Berindan Neagoe I Ioana

  71. 137 The effect of combined treatment, epirubicin (free/loaded in microspheres) and/or nifedipine, upon the evolution of the ehrlich ascites tumor

    Article • European Journal of Cancer, November 1995, Elsevier

    Professor Berindan Neagoe I Ioana

  72. 693 Correlation between PCNA and first generation markers in breast cancer prognosis

    Article • European Journal of Cancer, November 1995, Elsevier

    Professor Berindan Neagoe I Ioana